EICHOR
● Recruiting
Prospective Gastric Cancer Screening With Fecal Multi-target DNA Analysis
Condition: Gastric (Stomach) Cancer · Sponsor: Fudan University
About this study
This is a prospective study designed to evaluate the efficacy of a multi-target fecal DNA test for the early detection of gastric cancer. The test combines Helicobacter pylori gene detection with analysis of fecal methylated DNA markers. The primary objective is to assess whether each method, individually or in combination, can facilitate earlier diagnosis of gastric cancer. All participants will undergo the multi-target fecal DNA test and complete the gastric cancer risk questionnaire.
This description comes directly from the study's public registry record.
Talk to the study team
Dazhi Xu, PhD · 86-18121299796 · xudzh@fudan.edu.cn
Always discuss trial participation with your own doctor first.
Locations (1)
| People's Hospital of Tongling City | Tongling, China | Recruiting |
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06943807